Get the Stockscreener App
42.81
0.14%
-0.22
Spdr Pharmaceuticals Etf stock is traded at $42.81, with a volume of 2,040.
It is down -0.14% in the last 24 hours and down -5.19% over the past month.
See More
Previous Close:
$42.59
Open:
$42.81
24h Volume:
2,040
Relative Volume:
0.05
Market Cap:
$229.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.28%
1M Performance:
-5.19%
6M Performance:
-3.84%
1Y Performance:
+0.33%
1-Day Range:
$42.81
$42.81
1-Week Range:
$42.48
$44.30
52-Week Range:
$38.88
$48.76
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
Name
Spdr Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare XPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
42.81 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
274.25 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
557.60 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
560.23 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
221.10 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
475.01 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf Stock (XPH) Latest News
Select Sector SPDR ETFs: Strategic Investment with Sector-Specific Allocations - Financial Content
Federal Judge Halts National Institutes of Health's Grant Policy Overhaul Citing Legal Violations - Benzinga
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Nasdaq
Perrigo Outlines 2025 Growth Plans, Projects Sales Boost And Margin Expansion By 2027 - Benzinga
Sector Update: Health Care Stocks Steady Pre-Bell Friday - TradingView
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Ahead of Upcoming Economic Data - TradingView
Long Term Trading Analysis for (XPH) - Stock Traders Daily
Blue Trust Inc. Has $228,000 Holdings in SPDR Dow Jones Industrial Average ETF Trust (NYSEARCA:DIA) - Defense World
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports - Benzinga
Ken Griffin's Citadel Places Big Short Bet Against GSKHere's What It Means for Investors - Benzinga India
Learn to Evaluate (XPH) using the Charts - Stock Traders Daily
Unlocking the Mystery of Smart Beta: A Deep Dive into the iShares Biotechnology ETF - Clinique Bio
Best health care ETFs: Top biotech, pharma and medical funds - Bankrate.com
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - TradingView
Five ETFs to invest in to hedge against policy uncertainty in 2025 - TradingView
Blue Trust Inc. Increases Stock Holdings in SPDR Portfolio Emerging Markets ETF (NYSEARCA:SPEM) - Defense World
SPDR Dow Jones REIT ETF (NYSEARCA:RWR) Sees Large Volume Increase – Here’s What Happened - Armenian Reporter
SPDR Portfolio Emerging Markets ETF (NYSEARCA:SPEM) Shares Purchased by Money Concepts Capital Corp - Armenian Reporter
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)? - MSN
Viatris Stock Outlook: Is Wall Street Bullish or Bearish? - Inkl
When (XPH) Moves Investors should Listen - Stock Traders Daily
Can Health Care ETFs Aid Your Portfolio? - ETF Trends
7 Best-Performing Biotech ETFs for February 2025 - NerdWallet
JPMorgan Chase & Co. Boosts Stock Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Pfizer Stock Outlook: Is Wall Street Bullish or Bearish? - Inkl
Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Tuesday as Tech Sector Stabilizes Post-DeepSeek Selloff - TradingView
Select Sector SPDR ETFs: Strategic Portfolio Management through Sector-Specific Investments - ACCESS Newswire
Barclays PLC Sells 13,104 Shares of SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
How to Invest in SPDR S&P Biotech ETF (XBI) - The Motley Fool
(XPH) Proactive Strategies - Stock Traders Daily
3 Biotech Stocks With Notable Insider Buying - Seeking Alpha
ETFs Poised to Win or Lose Under Trump's New Policies - TradingView
JPMorgan Chase & Co. Acquires 530 Shares of SPDR Dow Jones REIT ETF (NYSEARCA:RWR) - Defense World
JPMorgan Chase & Co. Sells 47,417 Shares of SPDR Portfolio Corporate Bond ETF (NYSEARCA:SPBO) - Defense World
SPY ETF News, 1/16/2025 - TipRanks
McKesson, Vertex Pharmaceuticals among top healthcare Quant picks before Q4 earnings - Seeking Alpha
How To Trade (XPH) - Stock Traders Daily
Healthcare executives weigh policy unknowns at San Francisco gathering - Financial Times
SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Shares Sold by Jane Street Group LLC - Defense World
6 Best Health Care ETFs to Buy for 2025 | Investing - U.S News & World Report Money
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
Principal Financial Group Inc. Has $1.53 Million Position in SPDR Bloomberg High Yield Bond ETF (NYSEARCA:JNK) - Defense World
Stifel Financial Corp Invests $337,000 in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Stifel Financial Corp Buys Shares of 14,687 Franklin High Yield Corporate ETF (BATS:FLHY) - Defense World
Stifel Financial Corp Has $353,000 Position in JPMorgan International Bond Opportunities ETF (BATS:JPIB) - Defense World
XHE: 3 Healthcare ETFs for Defensive Investing - StockNews.com
3 Healthcare Stocks to Buy for a 2025 Rebound - Barron's
SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1548 - MSN
Should SPDR Portfolio S&P 500 ETF (SPLG) Be on Your Investing Radar? - Yahoo Finance
Stifel Financial Corp Sells 174 Shares of SPDR S&P Capital Markets ETF (NYSEARCA:KCE) - Defense World
SPDR S&P Regional Banking ETF Sees Unusually High Options Volume (NYSEARCA:KRE) - Defense World
Spdr Pharmaceuticals Etf Stock (XPH) Financials Data
There is no financial data for Spdr Pharmaceuticals Etf (XPH). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.02%
1.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):